Mayatepek E - Search Results

1

Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism.

Corda H, Kummer S, Welters A, Teig N, Klee D, Mayatepek E, Meissner T. Corda H, et al. Among authors: mayatepek e. Orphanet J Rare Dis. 2017 Jun 2;12(1):108. doi: 10.1186/s13023-017-0653-x. Orphanet J Rare Dis. 2017. PMID: 28576129 Free PMC article.

2

Sarcosinaemia in a patient with severe progressive neurological damage and hypertrophic cardiomyopathy.

Meissner T, Mayatepek E. Meissner T, et al. Among authors: mayatepek e. J Inherit Metab Dis. 1997 Sep;20(5):717-8. doi: 10.1023/a:1005347114782. J Inherit Metab Dis. 1997. PMID: 9323574 No abstract available.

3

Persistent hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical outcome and mutational analysis.

Meissner T, Brune W, Mayatepek E. Meissner T, et al. Among authors: mayatepek e. Eur J Pediatr. 1997 Oct;156(10):754-7. doi: 10.1007/s004310050706. Eur J Pediatr. 1997. PMID: 9365062

4

Congenital hyperinsulinism: molecular basis of a heterogeneous disease.

Meissner T, Beinbrech B, Mayatepek E. Meissner T, et al. Among authors: mayatepek e. Hum Mutat. 1999;13(5):351-61. doi: 10.1002/(SICI)1098-1004(1999)13:5<351::AID-HUMU3>3.0.CO;2-R. Hum Mutat. 1999. PMID: 10338089 Review.

5

Recurrent excessive transient hypertriglyceridaemia.

Meissner T, Mayatepek E. Meissner T, et al. Among authors: mayatepek e. Eur J Pediatr. 1999 Aug;158(8):683. doi: 10.1007/s004310051176. Eur J Pediatr. 1999. PMID: 10445351 No abstract available.

6

Exercise induced hypoglycaemic hyperinsulinism.

Meissner T, Otonkoski T, Feneberg R, Beinbrech B, Apostolidou S, Sipilä I, Schaefer F, Mayatepek E. Meissner T, et al. Among authors: mayatepek e. Arch Dis Child. 2001 Mar;84(3):254-7. doi: 10.1136/adc.84.3.254. Arch Dis Child. 2001. PMID: 11207177 Free PMC article.

7

Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome.

Santer R, Kinner M, Passarge M, Superti-Furga A, Mayatepek E, Meissner T, Schneppenheim R, Schaub J. Santer R, et al. Among authors: mayatepek e. Hum Genet. 2001 Jan;108(1):66-71. doi: 10.1007/s004390000432. Hum Genet. 2001. PMID: 11214910

8

Hyperinsulinism in syndromal disorders.

Meissner T, Rabl W, Mohnike K, Scholl S, Santer R, Mayatepek E. Meissner T, et al. Among authors: mayatepek e. Acta Paediatr. 2001 Aug;90(8):856-9. Acta Paediatr. 2001. PMID: 11529530

9

Clinical and genetic heterogeneity in congenital hyperinsulinism.

Meissner T, Mayatepek E. Meissner T, et al. Among authors: mayatepek e. Eur J Pediatr. 2002 Jan;161(1):6-20. doi: 10.1007/s004310100850. Eur J Pediatr. 2002. PMID: 11808881 Review.

10

Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of leukotrienes.

Ferdinandusse S, Meissner T, Wanders RJ, Mayatepek E. Ferdinandusse S, et al. Among authors: mayatepek e. Biochem Biophys Res Commun. 2002 Apr 26;293(1):269-73. doi: 10.1016/S0006-291X(02)00214-0. Biochem Biophys Res Commun. 2002. PMID: 12054595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters